Stay updated on pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Sign up to get notified when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.

Latest updates to the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check25 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of collaborators OncoSec Medical Incorporated and Merck Sharp & Dohme LLC, while significant details about the trial's methodology and patient criteria have been removed.SummaryDifference44%
Stay in the know with updates to pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.